1CM Inc (EPIC) AI Stock Analysis

1CM Inc

(CNQX:EPIC)

Select Model

Rating:63Neutral

Price Target:CAD 0.41▲(127.78% Upside)

Action:reiterated

Date:08/29/26

The score is driven mainly by improving financial performance (rapid revenue growth, a profitability turnaround, and low balance-sheet leverage), tempered by meaningful risks around earnings quality (very thin gross margin) and weak cash conversion (negative free cash flow). Technically the trend is strong, but extremely overbought signals reduce the near-term technical score. Valuation is supportive due to a low P/E, though dividend support is not available.

Positive Factors

Rapid Revenue GrowthRevenue scaling of roughly 54% demonstrates strong recent expansion from the company’s earlier base and provides a foundation for operating leverage. If this growth persists, it can broaden market reach, support reinvestment, and improve the durability of the business model over the next several quarters.

Negative Factors

Extremely Thin Gross MarginA gross margin near 1% leaves very little protection against cost increases, pricing pressure, or unfavorable mix changes. Even with revenue growth and positive net income, such limited gross profitability makes earnings more vulnerable and may constrain the company’s ability to reinvest sustainably.

1CM Inc (EPIC) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 26.30M
Dividend Yield: ―
Average Volume (3M): 13.77K
Price to Earnings (P/E): 4.5
Beta (1Y): 1.38
Revenue Growth: 7.36%
EPS Growth: 172.97%
Country: Canada
Employees: 11
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

1CM Inc Business Overview & Revenue Model

Company Description

1CM Inc. functions as a diverse enterprise within the cannabis industry. The company's primary focus is on utilizing technology to cater to individual consumers, with the objective of making cannabis markets more accessible and inclusive. Previously...

How the Company Makes Money

Publicly available, company-specific detail on 1CM Inc.’s current revenue model and major revenue streams is not available with sufficient specificity to describe factually without speculation; therefore null.

1CM Inc Financial Statement Overview

Summary

Strong top-line momentum (TTM revenue up ~54%) and a clear profitability turnaround support the score, and the balance sheet is a strength with low leverage (TTM debt-to-equity ~0.05) and improved equity/ROE (~15%). Offsetting this, margin quality and earnings quality are key risks: TTM gross margin is extremely thin (~1%) and cash conversion is weak with low operating cash flow versus net income (~0.04) and negative free cash flow.

Income Statement

64Positive

Balance Sheet

78Positive

Cash Flow

45Neutral

Financial statement breakdown
Breakdown	TTM	Nov 2025	Nov 2024	Aug 2023	Nov 2022	Aug 2021
Income Statement
Total Revenue	75.45M	73.37M	57.22M	35.34M	842.49K	341.81K
Gross Profit	875.02K	6.65M	11.18M	7.61M	-428.00K	-148.00K
EBITDA	2.92M	2.88M	2.86M	1.72M	-3.36M	-3.57M
Net Income	4.75M	484.85K	615.91K	-914.00K	-4.73M	-4.56M
Balance Sheet
Total Assets	44.31M	43.52M	39.87M	34.02M	28.23M	9.32M
Cash, Cash Equivalents and Short-Term Investments	9.61M	6.15M	4.97M	3.08M	2.24M	162.46K
Total Debt	1.54M	3.42M	7.85M	6.39M	11.13M	12.26M
Total Liabilities	10.29M	14.65M	12.14M	9.42M	12.85M	13.78M
Stockholders Equity	34.02M	28.87M	27.73M	24.60M	15.38M	-3.85M
Cash Flow
Free Cash Flow	-169.59K	2.51M	762.99K	-4.37M	-2.75M	-2.01M
Operating Cash Flow	329.50K	2.71M	2.47M	-1.75M	-2.53M	-1.99M
Investing Cash Flow	3.67M	-627.84K	-1.71M	1.33M	1.75M	-150.80K
Financing Cash Flow	-2.98M	-1.57M	1.13M	1.26M	2.85M	2.30M

1CM Inc Technical Analysis

Technical Analysis SentimentNegative

Last Price0.18

Price Trends

50DMA0.28Negative

100DMA0.20Negative

200DMA0.19Negative

Market Momentum

MACD-0.03Negative

RSI25.20Positive

STOCH-0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:EPIC, the sentiment is Negative. The current price of 0.18 is below the 20-day moving average (MA) of 0.20, below the 50-day MA of 0.28, and below the 200-day MA of 0.19, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 25.20 is Positive, neither overbought nor oversold. The STOCH value of -0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:EPIC.

1CM Inc Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:EPIC against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:EPIC	63Neutral	CAD 21.19M	4.47	15.10%	―	7.36%	172.97%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:LABS	49Neutral	CAD 27.77M	-5.60	-13.79%	―	-6.74%	43.54%
TSE:ROMJ	45Neutral	CAD 25.34M	-15.24	-4.00%	―	16.66%	-1007.41%
TSE:PCLO	42Neutral	CAD 9.34M	-2.67	28.59%	―	0.90%	57.73%
TSE:AVCN	41Neutral	CAD 14.11M	-3.24	-108.44%	―	-0.23%	-142.54%
TSE:GWAY	41Neutral	CAD 10.69M	-3.62	-35.33%	―	-1.41%	-78.91%

* Healthcare Sector Average

Performance Comparison

TSE:EPIC and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:EPIC	1Cm Inc.	0.18	-0.28	-60.44%
TSE:LABS	Medipharm Labs (Otc)	0.07	-0.01	-13.33%
TSE:PCLO	Pharmacielo	0.05	0.01	11.11%
TSE:ROMJ	Rubicon Organics	0.38	-0.13	-25.00%
TSE:AVCN	Avicanna Inc	0.10	-0.16	-60.38%
TSE:GWAY	Greenway Greenhouse Cannabis Corp.	0.08	-0.09	-52.94%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 29, 2026

1CM Inc AI Stock Analysis